摘要
目的分析在治疗反流性食管炎中应用雷贝拉唑联合莫沙必利的治疗效果。方法选取苏州市吴江区第四人民医院2018年4月至2019月7月收治的40例反流性食管炎患者作为本次研究对象,采用电脑随机抽取的方法将患者分为对照组和观察组,各20例。2组均给予雷贝拉唑治疗,观察组同时给予莫沙必利治疗,比较2组疗效及不良反应发生率。结果观察组治疗总有效率明显高于对照组(95.00%vs.80.00%,P<0.05),不良反应发生率明显低于对照组(10.00%vs.25.00%,P<0.05)。结论在治疗反流性食管炎中,应用雷贝拉唑联合莫沙必利的治疗效果显著优于单纯应用雷贝拉唑的治疗效果。
Objective To analyze the therapeutic effect of rabeprazole combined with mosapride in the treatment of reflux esophagitis.Methods Totally 40 patients with reflux esophagitis were selected from Suzhou Wujiang District Fourth People's Hospital from April 2018 to July 2019,and were evenly divided into two groups using computer random selection.Both groups were treated with rabeprazole,the observation group was treated with mosapride at the same time.The effect and incidence of adverse reactions of the two groups were compared.Results The total effective rate of the observation group was higher than that of the control group(95.00%vs.80.00%,P<0.05);the incidence of adverse reactions in the observation group was lower than that in the control group(10.00%vs.25.00%,P<0.05).Conclusion In the treatment of reflux esophagitis,the effect of rabeprazole combined with mosapride is better than that of rabeprazole alone.
作者
廖建辉
LIAO Jianhui(Suzhou Wujiang District Fourth People's Hospital,Wujiang,Jiangsu 215231,China)
出处
《大医生》
2020年第4期99-100,共2页
Doctor
